Sangeeta Bhatia Looks at Life's Architecture

Credit: Photo: Jason Varney/varneyphoto.com" /> Credit: Photo: Jason Varney/varneyphoto.com Although her research interests run the gamut from cell and molecular biology to nanotechnology and biomedical engineering, one organ attracts the bulk of Sangeeta Bhatia?s attention: the liver. Her mother, who grew up in Bombay, told her that the philosophers of ancient Greece and India considered the liver the ?center of everything.? Now the director of the Laboratory for Multiscale Regenerati

Written bySteve Nadis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although her research interests run the gamut from cell and molecular biology to nanotechnology and biomedical engineering, one organ attracts the bulk of Sangeeta Bhatia?s attention: the liver. Her mother, who grew up in Bombay, told her that the philosophers of ancient Greece and India considered the liver the ?center of everything.? Now the director of the Laboratory for Multiscale Regenerative Technologies at Massachusetts Institute of Technology, Bhatia shares that view.

Bhatia is working on engineering healthy, implantable liver tissue as an alternative for the tens of thousands of people currently awaiting liver transplants. The first challenge is to culture liver cells outside the body while preserving their functionality. ?Architecture is critical,? she says. ?If you arrange the cells properly, surrounding them with the right neighbors, you can create an environment and community that functions better.?

Borrowing techniques such as photolithography from the microchip industry, Bhatia and her colleagues have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies